convalescent plasma treatment living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

5406	Duan, 2020	1	13	4		not a RCT	high risk of bias
5446	Sean, 2020	1	13	4		not a RCT	high risk of bias
5549	Hegerova, 2020	1	13	4		not a RCT	high risk of bias
5550	Abolghasemi, 2020	1	13	4		not a RCT	high risk of bias
5569	Dai W, 2020	2	13	4	excluded	not a RCT	high risk of bias
5662	Salazar, 2020	1	13	4		not a RCT	high risk of bias
5761	Joyner, 2020	1	31	3		not a RCT	high risk of bias
6159	Gemici, 2020	0	13	0	selection pending
6940	Bihariesingh-Sanchit (SuriCovid), 2021	1	31	0		not a RCT	risk of bias not avaialble

	COVID 19 outpatients
convalescent plasma treatment	CoV-Early ... C3PO CONV-ERT